A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy
Clinical trial NCT03150602 · UNKNOWN
Trial details
- NCT number
- NCT03150602
- Sponsor
- Taiwan Mundipharma Pharmaceuticals Ltd.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-30
- Primary completion
- 2020-12-31
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.